Gsk (GSK) Sale and Maturity of Investments (2009 - 2025)
Gsk (GSK) reported Sale and Maturity of Investments - Total of -$159.62 million for the quarter ended Dec 31, 2025, compared with $2.57 million a year earlier.
Gsk (GSK) Sale and Maturity of Investments (2009 - 2025) Analysis & Trends
For the year ended Dec 31, 2025, Gsk posted Sale and Maturity of Investments - Total of $249.2 million, down 91.7% from the prior year.
- Sale and Maturity of Investments - Total has a five-year compound annual growth rate of -43.2% (years ended Dec 2020 to Dec 2025).
- By year, Sale and Maturity of Investments - Total came in at $3.01 billion in the year ended Dec 31, 2024 (+32.1%), $2.28 billion in the year ended Dec 31, 2023 (+674.0%), $294.55 million in the year ended Dec 31, 2022 (+6.0%) and $277.93 million in the year ended Dec 31, 2021 (-93.4%).
- The figure for the quarter ended Dec 31, 2025 ranks as the lowest quarterly Sale and Maturity of Investments - Total in data going back to the quarter ended Sep 30, 2009.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Investments Sold (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | - |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | - |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 308.00 Mn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | - |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 405.00 Mn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | 88.00 Mn |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | - |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | Pfizer | 156.44 Bn | 103.79 Bn | 12.56 Bn | 2.53 Bn |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -159.62 Mn |
| Dec 31, 2024 | 2.57 Mn |
| Mar 31, 2024 | 1.34 Bn |
| Dec 31, 2023 | 1.24 Bn |
| Mar 31, 2023 | 12.16 Mn |
| Dec 31, 2022 | 144.27 Mn |
| Dec 31, 2021 | -48.53 Mn |
| Dec 31, 2020 | 178.26 Mn |
| Dec 31, 2019 | 23.14 Mn |
| Sep 30, 2019 | 14.80 Mn |
| Dec 31, 2018 | 86.21 Mn |
| Dec 31, 2017 | 272.17 Mn |
| Dec 31, 2016 | 610.42 Mn |
| Mar 31, 2016 | 5.73 Mn |
| Dec 31, 2015 | 22.76 Mn |
| Dec 31, 2014 | 282.02 Mn |
| Sep 30, 2014 | 8.36 Mn |
| Mar 31, 2014 | 18.20 Mn |
| Dec 31, 2013 | 45.33 Mn |
| Sep 30, 2013 | 9.30 Mn |
Gsk Sale and Maturity of Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=GSK&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "sale-and-maturity-of-investments", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();